Efficacy and Safety of Ofatumumab Compared to Teriflunomide in Patients With Relapsing Multiple Sclerosis.
Clinical trial NCT02792231 · COMPLETED
Trial details
- NCT number
- NCT02792231
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2016-08-26
- Primary completion
- 2019-07-10
- Enrollment
- 955
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.